| | |
PXN expression
| |
|---|
|
Characteristics
|
Total No.
|
Low No. cases (%)
|
High No. cases (%)
|
P value
|
|---|
|
Age
| | | |
0.742
|
|
< 60
|
116
|
75(49.3)
|
41(47.1)
| |
|
≥ 60
|
123
|
77(50.7)
|
46(52.9)
| |
|
Gender
| | | |
0.096
|
|
Male
|
177
|
118(77.6)
|
59(67.8)
| |
|
Female
|
62
|
34(22.4)
|
28(32.2)
| |
|
Tumor depth
| | | |
0.527
|
|
T1
|
11
|
9(5.9)
|
2(2.3)
| |
|
T2
|
29
|
20(13.2)
|
9(10.3)
| |
|
T3
|
176
|
109(71.7)
|
67(77.0)
| |
|
T4
|
23
|
14(9.2)
|
9(10.4)
| |
|
Lymph node invasion
| | | |
0.656
|
|
N0
|
55
|
35(23.0)
|
20(22.9)
| |
|
N1
|
85
|
58(38.2)
|
27(31.0)
| |
|
N2
|
64
|
39(25.6)
|
25(28.7)
| |
|
N3
|
35
|
20(13.2)
|
15(17.4)
| |
|
Distant metastasis
| | | |
0.001a
|
|
M0
|
173
|
121(79.6)
|
52(59.7)
| |
|
M1
|
66
|
31(20.4)
|
35(40.3)
| |
|
Differentiation status
| | | |
0.388
|
|
Well
|
99
|
68(44.7)
|
31(35.6)
| |
|
Moderate
|
92
|
55(36.1)
|
37(42.5)
| |
|
Poor and others
|
48
|
29(19.2)
|
19(21.9)
| |
|
TNMb stage
| | | |
0.021a
|
|
I
|
28
|
20(13.1)
|
8(9.1)
| |
|
II
|
37
|
23(15.1)
|
14(16.1)
| |
|
III
|
100
|
72(47.3)
|
28(32.2)
| |
|
IV
|
74
|
37(24.5)
|
37(42.6)
| |
|
Treatment
| | | |
0.386
|
|
Surgery only
|
116
|
77(50.7)
|
39(44.8)
| |
|
Surgery + chemotherapy
|
123
|
75(49.3)
|
48(55.2)
| |
|
Survival status
| | | |
0.004a
|
|
Alive
|
98
|
73(48.0)
|
25(28.7)
| |
|
Dead
|
141
|
79(52.0)
|
62(71.3)
| |
- aP < 0.05, Chi-square test; bTNM: T, tumor; N, lymph node; M, distant metastasis.
